Metal protein attenuating compounds for the treatment of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Metal protein attenuating compounds for the treatment of Alzheimer's disease

Metal protein attenuating compounds for the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q24242031

about

Metal protein attenuating compounds for the treatment of Alzheimer's dementia Metal protein attenuating compounds for the treatment of Alzheimer's dementia The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+.Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model.

P2860

Q24197913-F55646E1-0E7D-450B-A496-0502FD69DF6A Q24200310-3869DE25-0E22-43DC-99D6-1A7D22B9225F Q33755982-43BD18C3-F17A-4CB6-A46E-83D5C186AE77 Q37198579-FB5B36A6-F1AE-4955-8590-9C99EBCF86AE Q37208534-F2B24CBD-E3D1-45F5-A9D8-4BFAE74B45C3 Q37279999-5DC0478A-5C2E-4000-A913-480CE5836BB2 Q38015346-50DB65D5-E892-4EC5-A73F-6572AF4C4D13

P2860

Metal protein attenuating compounds for the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q24242031

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@ast

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en-gb

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@nl

type

label

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@ast

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en-gb

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@nl

prefLabel

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@ast

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en-gb

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@nl

P1433

Q24242031-82D4DC06-748F-4F67-8F6F-A8ED72475EE5

P1476

Q24242031-56A2849C-4F52-4DAE-A40E-BE344C92A355

P2093

Q24242031-34A60E71-E86F-4A2C-AADF-9698D8CB72E7

Q24242031-C1D796A4-1513-4B46-89A7-08CF41FD4D27

Q24242031-CB7B07F5-05FC-4D74-A110-CB09CDDC2BB4

P2860

Q24242031-29A7AAD6-1467-41C2-A61C-2458C40120B8

Q24242031-4B3647EA-5D5C-4FF7-9681-B683DA301541

Q24242031-59E10F57-2A28-46F2-ADF5-B5AB4B4AC10E

Q24242031-5E90839F-2AFB-4EE4-960F-B4FCE50C159B

Q24242031-78BCFCF7-CEAC-4F21-AEDE-C5F67CB01BB6

Q24242031-829A3797-8929-4D1F-AE33-86EB1E8B2734

Q24242031-978C972F-7B5C-495B-8446-F4C605E2E49C

Q24242031-C40D775B-3AF5-40B8-8FD2-C47836D414CF

Q24242031-D108F814-EC85-467F-B2F0-48E136373284

Q24242031-D18BB4F8-BD45-4F32-9927-95EACA6278CC

P31

Q24242031-5F6BFE99-4EF9-4ED8-9C1A-67A877EA9C49

P356

Q24242031-C721DF45-26ED-43DF-9E92-FAEA36B76863

P577

Q24242031-7502C824-7E35-4B7E-AD84-C626E4AC675D

P698

Q24242031-2E452C98-0C38-47FE-B59F-1547A8236E8C

P921

Q24242031-35F19E60-A380-421F-B1E9-363AE3CF7CAB

P356

14651858.CD005380.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Metal protein attenuating compounds for the treatment of Alzheimer's disease

@en

P2093

Elizabeth L Sampson

http://www.w3.org/2001/XMLSchema#string

Lydia Jenagaratnam

http://www.w3.org/2001/XMLSchema#string

Rupert McShane

http://www.w3.org/2001/XMLSchema#string

P2860

Clioquinol for the treatment of Alzheimer's Disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.

The metallobiology of Alzheimer's disease.

Current status of metals as therapeutic targets in Alzheimer's disease.

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol.

P31

scholarly article

P356

10.1002/14651858.CD005380.PUB3

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18254079

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease